Publication | Open Access

Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma

AsthmaAllergyAllergy MedicineImmunologyAllergenImmunotherapyMedicineAnti-ige AntibodyClinical AllergyAllergic Asthma